Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
Designer natriuretic peptides: a vision for the future of heart failure therapeutics.
2011-08-04

Despite recent pharmacological advances in heart failure therapy, mortality from acute decompensated heart failure remains high. Conventional therapies are often insufficient to address the complex interplay between structural, functional, neurohumoral, and renal mechanisms involved in the heart failure syndrome. The natriuretic peptide system, however, ...

PubMed

2
Characterization of atrial natriuretic peptide degradation by cell-surface peptidase activity on endothelial cells
1993-01-01

Atrial natriuretic peptide (ANP) is a fluid-regulating peptide hormone that promotes vasorelaxation,

NASA Technical Reports Server (NTRS)

3
Brain natriuretic peptide measurement in pulmonary medicine.
2011-08-01

Serum levels of natriuretic peptides are well established as important biomarkers in patients with cardiac disease. Less attention has been placed on the role of natriuretic peptides in patients with pulmonary conditions. In several well-defined groups of patients with pulmonary disease ...

PubMed

4
B-type natriuretic peptide: diagnostic and therapeutic applications in infants and children.
2011-02-13

The natriuretic peptide system plays an active role in the regulation of fluid balance and systemic vascular resistance. Peptides of the natriuretic system produced through recombinant DNA technology are now available for clinical use including both atrial natriuretic ...

PubMed

5
Characterization of atrial natriuretic peptide receptors in brain microvessel endothelial cells

Atrial natriuretic peptide (ANP) binding and ANP-induced increases in cyclic guanosine monophosphate

NASA Technical Reports Server (NTRS)

First Page Previous Page 1 Next Page Last Page